![]() |
|
Flavay's™ strong antioxidant
power is patented—as a scavenger
of the free radicals that play a major role in the degradation of collagen and initiation, duration and breakdown of inflammation. That means that your joints hurt less and your blood flows better... ![]()
For more than 60 years this antioxidant complex, now known as Flavay®, has produced stunning health results across Europe. The benefits of Flavay® are particularly compelling because they address so many diverse body tissues and conditions. Below is an overview of Flavay's™ proven health benefits:
What is Flavay®?
Flavay® is more than a single nutrient. It is a very specific, standardized and isolated, singular polyphenol complex defined and perfected by Dr. Jack Masquelier in France; validated by the French Ministry of Health and documented by a library of research consisting of many patents and hundreds of scientific papers, articles, doctorate theses, lectures and presentations. Flavay® is not a simple bioflavonoid (this is important because many are non-bioavailable or even toxic). Flavay® is a highly specialized, nutritional complex of pairs and triples of a specific molecule called "flavan-3-ol," isolated from natural extracts, that has been extensively tested and examined clinically for biological antioxidant protection, collagen strengthening, tissue rebuilding, and other health producing outcomes. This highly defined, polyphenol complex is proven fully bioavailable, safe and effective by numerous human studies, manufactured in France and used worldwide since 1950. "Radical Scavenger Effect"
of Flavay® Patented and licensed in France for therapeutic uses, the U.S. Government granted Dr. Masquelier a patent on October 6, 1987 which allows his proanthocyanidins complex, now sold as Flavay®, to be used as an antioxidant here in the United States.
During any challenge to your immune systembecause of disease, infections, toxic exposure, stress or agingyou need the extra antioxidant power in Flavay® to help scavenge the free radicals naturally produced by the immune system's cells during warfare. When your immune system works better, your joints hurt less and your blood flows better. Method of Action Considerable research has demonstrated that Flavay® has several key actions when consumed:
Free Radicals: Both Foe and Friend Contemporary scientific studies in neurology and immunology have demonstrated that the body's own immune system has the ability to damage healthy cells. When the body's immune system mobilizes, our cells produce by-products called oxygen free radicals, like pellets of poison, that go to work to destroy invaders by interfering with their cellular machinery, literally dissolving or breaking down the genetic material of bacteria, toxins, and viruses. When all is going well, the immune system is capable of identifying foreign invaders such as viruses and bacteria. If functioning properly, our immune components do not turn against our own body's cells. Unfortunately, free radicals can interfere with the biological components of our healthy cells just as they destroy invaders, literally dismantling the body's essential cellular proteins, fatty cell membranes and DNA.
The most important natural defenses we have against free radical damage are our body's natural "antioxidants," a broad range of chemical substances that all have one thing in common: they ward off free radical damage to cells. However, in many neurological diseasesincluding Parkinson's, Alzheimer's, chronic fatigue, and multiple sclerosisthe brain's specialized antioxidant mechanisms fail. The cause of the failure might be genetic, environmental, or even dietary, but the consequences are the same: unchecked free radical activity on the brain. The excessive production of one free radical in particular, nitric oxide, can be blamed for throwing the brain-immune systems off kilter and causing some of the brain's worst free radical damage. Over the past decade, scientists have shown that the overproduction of nitric oxide through a combination of immune and nervous system activity often sparked by an infection, exposure to a toxin, or as part of the aging processplays a key role in the development of neurological diseases. Antioxidants:
Antioxidants can neutralize free radical attacks and are especially important as we age. During any challenge to your immune systembecause of disease, infections, toxic exposure, stress or agingyou need extra antioxidants to help scavenge the free radicals naturally produced by the immune system's cells during warfare. Until recently, scientists believed that each antioxidant worked separately in the body, independently of the others. We now know that isn't true. Current research demonstrates that key antioxidants and their co-factor nutrients work synergistically with one another in the body. Antioxidants work together in the bodynot alone. Superior Antioxidant Support Flavay® is superior to other antioxidants because its protective effects are multiplied in the body: while it provides its own, powerful antioxidant protection, it also supports the dynamic interplay between other antioxidants in the body. Flavay's™ ability to recycle, or regenerate vitamins C and E after they have quenched free radicals vastly extends their unique antioxidant powers, helping the body to maintain its synergistic antioxidant balance.
Flavay® is rapidly absorbed and very quickly distributed throughout
the body. As a free radical fighter, Flavay® comes to the aid of
the body more quickly than other antioxidants, reducing the potential
for free radical damage and the ravages of aging. Flavay® also possesses
more reactive sites for neutralizing free radicals than other known antioxidants.
Furthermore, Flavay® permits reactivity with both positively and
negatively charged free radical species. What this means is that Flavay®
can quench or scavenge (neutralize) a broad variety
of free radicals. Highly reactive as an antioxidant in both lipid (fat)
and aqueous (water) phases, Flavay® neutralizes oxygen free radicals
and is a valuable protector of healthy cells in a variety of internal
conditions. This is a unique property among antioxidants, as most work
either in lipid or aqueous phases, but not both. Research shows that Flavay®
can regulate nitric oxide and quench superoxide and the hydroxyl radical.
This is extremely important. Of all the free radicals formed in the body,
the hydroxyl radical is the most dangerous because it can directly attack
DNA. As a free radical scavenger, Flavay® is like an antioxidant
prize fighter that can successfully take on all challengers, big or small,
in any kind of weather.
|
![]() All About
Flavay | Flavay
Plus | What
Does it Do? | Proven Safety | Directions for Use | Q&A
Comparative Analysis | Endorsements & Testimonials | Free Research Brochure | BUY NOW
|
| REFERENCES: | Top |
||
| Masquelier, J. Plant extract with a proanthocyanidins content
as a therapeutic agent having radical scavenging effect and use thereof.
U.S. Patent No. 4,698,360, 1987. Masquelier, J. A lifetime devoted to OPC and Pycnogenols. Alfa Omega Editrice, Pub., 1996. Schwitters, B., Masquelier, J. OPC in practice. Alfa Omega Editrice, Publishers, 1995. Kilham, C., Masquelier, J. OPC: The miracle antioxidant. Keats Publishing, Inc., 1997. Mindell, E., et al. Earl Mindells vitamin bible for the 21st century. Warner Books, Inc., 1999. Passwater, R.A. The antioxidants: the nutrients that guard your body. Keats Publishing, Inc., 1985. Barilla, J. et al. The nutrition superbook: volume 1: the antioxidants. Keats Publishing, Inc., 1995. Facino RM, et al. Free radical scavenging action and anti-enzyme activities of procyanidines from Vitis vinifera. A mechanism for their capillary protective action. Arzneimittelforschung, 44: 592-601, 1994. Kuttan R, et al. Collagen treated with catechin becomes resistant to the action of mammalian collagenase. Experientia, 37: 221-223, 1981. Masquelier, J., et al. Stabilization du collagene par les oligomeres procyanidoliques. Acta Therapeutica, 7:101-105, 1981. Masquelier, J. Aspects pharmacologiques nouveaux de certains flavonoides. A Vie Medical 12:1969. Laparra, J., et al. Etude pharmaco-cinetique des oligomers procyandoliques totaux du raisin. Acta Therapeutica, 4, 1978. Laparra, J., et al. Etude pharmacocinetique des oligomeres flavonoliques. Plantes med et phyto, Tome XI, pp. 133-142, 1977. Robert A.M.; Groult, N.; Six, C.; Robert, L. Etude de laction des oligomeres procyanidoliques sur des cellules mesenchymateuses en culture. Ii lattachment des fibres elastiques aux cellules. (Study of the effect of procyanidolic oligomers on mesenchymal cells in culture. Ii attachment of elastic fibers to the cells.) Pat Biol, (30)6:601-7, 1990. Porter, Lawrence J., Wong Rosalind Y. Chan, Bock G. The molecular and crystal structure of (+)-2,3-trans-3,4-trans-leucocyanidin [(2r,3s,+r)-(+)-3,3, 4.4, 5.7-Hexahydroxyflavan] dihydrate, and comparison of its heterocyclic ring conformation in solution and the solid state. Journal of the Chemical Society; Perkin Transactions I 1985. pp. 1413-17. Masquelier, J. Proanthocyanidins et radicaux libres. 1985. Uchida, S., et al. Condensed tannins scavenge active oxygen free radicals. Med Sci Res, (15) 1987. pp. 831-832. Ariga, T. Radical scavenging action and its mode in procyanidins b-1 and b-3 from azuki beans to peroxyl radicals. Agric Biol Chem, 54(10) 1990. pp. 2499-2504. Da Silva, R., et. al. Radical scavenger capacity of different procyanidins from grape seeds. Presented at a symposium, Free radicals in biotechnology and medicine. Royal Society Of Chemistry, London January 1990, pp. 79-80. Bauman, J., Wurm, G., Bruchhausen, F. Hemmung der prostagladinsynthetase durch flavonoide und phenolderivate im vergleich nit deren 02 radikalfangereigenschaften Arch Pharm, (Weinheim) 313 (1980) pp. 330-337. Lombard, J., et al. The brain wellness plan. Kensington Pub. Corp., 1998. Braverman, E., et al. The healing nutrients within: in facts, findings and new research. Keats, 1987. Facino, R.M., et al. Free radical scavenging action and anti-enzyme activities of procyanidines from vitis vinifera. A mechanism for their capillary protective action. Arzneimittelforschung, 44: 592-601, 1994. Kuttan, R., Donnelly, P.V., Di Ferrante, N. Collagen treated with catechin becomes resistant to the action of mammalian collagenase. Experientia, 37: 221-223, 1981. Masquelier, J. Procyanidolic oligomers. J Parums Cosm Arom, 95: 89-97, 1990. Tixier, J.M., et al. Evidence by in vivo and in vitro studies that binding of pycnogenols to elastin affects its rate of degradation by elastases. Biochem Pharmacol, 33: 3933-3939, 1984. Kakegawa, H., et al. Chem. Pharm. Bull. 33:5079, 1985. Harmand, M.F., Blanquet, P. The fate of total flavanolic oligomers extracted from vitus vinifera l. in the rat. European Journal of Drug Metabolism and Pharmaccokinetics. 1978, No. 1 pp. 15-30. Delrieu, P., Ding J., Escande, B., Samain, D. Free-radical scavenging activity of proanthocyanidolic oligomers encapsulated in glycospheres: an in vivo and in vitro study. Cosmetology Department & S Biovectors, Ramonville St. Agne France. pp. 1-9. Meunier, M.T., Villie, F., et al. Inhibition of angiotensin i converting enzyme by flavanolic compounds: in vitro and in vivo studies. Planta Medica, May 26, 1986. pp. 12-15. Barbier, A., et al. Activite angioprotectrice des oligomeres procyanidolques chez lanimal-oedenme de la patte. Sanofi Res Toul Cedex Fr, pp31-40. Barbier, A., et al. Activite angioprotectrice des oligomeres procyanidolques chez lanimal-activite aniagoniste vis-a-vis des mediateurs de linflamation. Sanofi Res Toul Cedex Fr, pp. 31-40. Dubos, C., Durst, G., Hugonot, H. Evolution de la resistance capillaire, spontanement ou artificiellement diminuee par laction dune substance capillaro-toxique chez des personnes agees--action benefique dun agnet actif sur la micro-circulation: lEndotelon. Inform. Therapeut. 1980. pp. 302-305. Dartenuc, J.Y., et al. Resistance capillaire en geriatrie etude dun microangioprotecteur-Endotelon. Bordeaux Med. 13:903-7, 1990. Lagrue, G., Olivier-Martin, F., Grillot, A. Etude des effets des oligomeres du procyanidol sur las resistance capillaire dand lhypertension arterielle et certaines nephropathies. Sen. Hosp. Paris 18-25 Septembre, 1981. Beylot, C., Bioulac, P. Essai therapeutique dun angioprotecteur peripherique, lEndotelon. Actualite Therapeutique Gaz. Med. de France (87)22:2919-24, 1980. Lesbre, F.X., Tigaud, J.D. Effect de lEndotelon sur lindice de fragilite capillaire dan une population specifique: les sujets cirrhotiques. Gaz. Med. de France, (90)24 1983. Sarrat, L. Abord therapeutique des troubles fonctionnels des membres inferieurs par un microangioprotecteur lEndotelon. Bordeaux Med, 11:685-8, 1981. Delacroix, P. Etude en double aveugle de lEndotelon dans linsuffisance veineuse chronique. Therapeutique, la Revue de Medicine, (27-28) Sept. 1981. pp. 1793-1802. Thebaut, J.F, Thebaut, P., Vin, F. Etude de lEndotelon dand les manifestations fonctionnelles de linsuffisance veineuse peripherique-resultats dune etude en double aveugle portant sur 92 patients. Gazette Medicale, (92)1, 1985. pp. 96-100. Wegrowski, J., Robert, A.M., Maczar, M. The effect of procyanidolic oligomers on the composition of normal and hypercholesterolemic rabbit aortas. Biochem. Pharmacol, (33)21. 1984. pp. 3491-3497. Chang, W.C., Hsu, F.L. Inhibition of platelet aggregation and arachidonate metabolism in platelets by procyanidins. Prostagland Leukotri Essent Fatty Acids, 38:181-8, 1989. Masquelier, J. Pycnogenols: recent advances in the therapeutical activity of procyanidins. Supplement of Planta Medica, Journal of Medicinal Plant Research and Journal of Natural Products, July 1980 pp. 243-256. Henning, B., et al. Lipid peroxidation and endothelial cell injury: implications in atherosclerosis. Free Rad Path & Med, (4)1988 pp. 99-106. Masquelier, J. Les procyanidols du vin leur role dans lalcoolisme. pp. 88-93. Gazave, J.M. Notions recentes sur les capillaires unpub. bulletin from the Laboratoire De Physiologie Patholigie pp. 26-29. Ruf, J.C. Wine and polyphenols related to platelet aggregation and atherothrombosis. Office International Vigne et du Vin, Nutrition and Health Unit, Paris France; Drugs under Experimental and Clinical Research (Switz.) 25/2-3 (125-131), 1999. Blaszo, G. Gabor, M. Oedema-inhibiting effect of procyanidin. Acta Physiologica Academiae Scientiarum Hungaricae, Tomus 56(2):235-240, 1980. Tayau, M.F, LeFevre, G. Action du leucocyanidol sur lhyalaluronidase. Bull Soc Pharm Bordeaux, 95:132-136, 1956. Lamy, M. Utilization des oligomeres procyanidoliques en gynecologie. Essai Therapeutique Tomel (14) Sept. 2, 1981. pp. 1021-22. Henriet, J.P Une Etude Exemplaire Pour Un Phlebotrope: letude EIVE. Unpub., pp. 77-83. Pfister, A., Simon, M.T., Gazave, J.M. Sites de fixation des oligomeres procyanidoliques dans la paroi des capillaires sanguins du poumon decobaye. Acta Therapeutica (8) 1982. pp. 223-237. Kuttan, R., Donnelly, P., Di Ferrante, N. Collagen treated with (+) -catechin becomes resistant to the action of mammalian collagenase. Laboratory of Connective Tissue Research, Dept. of Biochem. Baylor Col. of Med., Houston TX. 28, May, 1980. Gendre, P., Laparra, J., Barraud, E. Effect protecteur des oligomeres procyanidoliques sur le lathyrisme experimental chez le rat. Ann. Pharm. Francaises, (43)1, 1985 pp. 61-73. Corbe, C., Boissin, J.P., Siou, A. Light vision and chorioretinal circulation. Study of the effect of procyanidolic oligomer (Endotelon). Jn. Fr. Opthalmol, (11)5:453-460, 1988. Boissin, J.P., Corbe C., Siou, A. Chorioretinal circulation and dazzling: use of procyanidol oligomers (Endotelon). Bull Soc Ophtalmol Fr, 88(2):173-4, 177-9, 1988. Proto, F. et al. Electrophysical study of vitis vinifera procyanoside oligomers effects on retinal function in myopic subjects. Ann Ott Clin Ocul, 114:85-93, 1988. Saracco, J.B., Estachy, G.M. Etude d lEndotelon en opthalmologie. Gaz Med de France, 88:2035-2038, 1981. Scharrer, A., Ober, M. Anthocyanosides in the treatment of retinopathies. Klin Monatsbl Augenheilkd, 178:386-389, 1981. Corbe, C., et al. Microangiopathy of the retina. J. Fr. Opthalmol, 11:453, 1988. Verin, M.M., Vildy, A., Maurin, J.F., Retinopathies et O.P.C. Bordeaux Medicale, (16)11. pp. 1467-74, 1978. Soyeux, A. et al. Endotelon. Diabetic retinopathy and hemorheology. Bull Soc Ophtalmol Fr. 87(12):1441-4, 1987. Fromantin, M. Les oligomeres procyanidoliques dans le traitement de la fragilite capillaire et de la retinopathie chez les diabetiques. A propos de 26 cas. Med Int, 16(11):432-434, Nov. 1981. Arne, J.L. Contribution a letude des oligomeres procyanidoliques: Endotelon, dans la retinopathie diabetique (a propos de 30 observations). Gaz. Med. de France, Vol. 89, No. 30, Oct. 8, 1982. Baruch, J. Effect of Endotelon in postoperative edema. Results of a double-blind study versus placebo in 32 female patients. Ann Chir Plast Esthet 29(4):393-5, 1984. Rao, C.N. et al. Influence of bioflavonoids on the collagen metabolism in rats with adjuvantinduced arthritis. Ital J Biochem. 30:54-62, 1981. Gabor, M. Pharmacologic effects of flavonoids on blood vessels. Angiologica, 9:355-374, 1972. Havsteen, B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol, 32:1141-48, 1983. Reimann, H.J., Lorenz, W., Fischer, M., Frölich, R., Meyer, H.J. Berkhauser Verlag, Vol. 7/1, Univ. of Marburg/Lahn, Ger., 1977. Masquelier, J. Action protectrice du vin sur lulcere gastrique. Resultats, p. 61. Amella, M., et al. Inhibition of mast cell histamine release by flavonoids and bioflavonoids. Planta Medica, 5116-20, 1985. Packer, L., et al. The antioxidant miracle: your complete plan. John Wiley & Sons, Inc., 1999. Shaw, R. How [Australian] PycnoGenol [MASQUELIERs®] Helps Sports People. Masquelier, J. Procyanidolic oligomers (leucocyanidins). Parfums Cosmet Arom 95:89-97, 1990. Pecking, A., Desprez-Curely, J.P., Megret, G. Oligomers procyanidoliques (Endotelon) dans le traitement des lymphoedemes post-therepeutiques de members superieurs. Symposium Satellite, Congres International dAngiologie, Toulouse, France, 4-7 Oct. 1989. Fahey, T.D., Pearl M. Hormonal effects of phosphatidylserine during 2 weeks of intense training. Abstract submitted to national meeting of the Amer College of Sports Medicine, June 1998. Monteleone, P., Maj, M., Beinat, L., Natale, M., Kemali, D. Blunting by chronic phosphatidylserine administration of the stress-induced activation of the hypothalamo-pituitary-adrenal axis in healthy men. Eur J Clin Pharm 43: 385388, 1992. Fahey, T.D., et al. The hormonal and perceptive effects of phosphatidylserine administration during two weeks of resistive exercise-induced overtraining. Bio of Sport 15(3):135-44, 1998. Laparra, J., Michaud, J. Masquelier, J. Action des oligomeres procyanidoliques sur le cobaye carence en vitamin c. Tavaux Originaux, University of Bordeaux, 1976. Masquelier, J. Action comparee de divers facteurs vitaminiques p sur loxydation de lacide ascorbique par les ions cuivriques. Bull. de la Societe de Chimie Biologique XXXIII (3-4) 1951. pp. 302-304. Masquelier, J. Action comparee de divers facteurs vitaminiques p sur lacide ascorbique-oxydase. Bull. de la Societe de Chimie Biologique XXXIII (3,4) 1951. pp.304-306 Kakegawa, H., Matsumoto, H., Endo, K., Satoh, T., Nonaka, G., Mishioka, I. Inhibitory effects of tannins on hyaluronidase activation and on the degranulation from rat mesentery mast cells. Chem. Pharm. Bull. 33(11)1985. 5079-5082. Reiman, H.J., Lorenz, M., Fischer, R., Frolich, H., Meyer, J. Histamine and acute haemorrhagic lesions in rat gastric mucosa: prevention of stress ulcer formulation by (+)-catechin, an inhibitor of specific histidine decarboxylase in vitro. Dirkhauser Verlag,Vol. 7/1, 1977. Pariente, J.J. Parientl-Amsellem, J. Les oedemes post-traumatoqies chez le sportif: essai controle de lEndothelon. Actualite Therapeutique 90(3) 2/11 1983 pp. 231-235. Masquelier, J., et al. Flavonoids et Pycnogenols Int J Vit Nut Res, (49)3:307-311, 1979. Yu, C. L. et al. Mutagenicity of proanthocyanidins. Food Chem. Toxicol. 25(2):135-9, 1987. Pantaleoni, G.C., Quaglino, D. Univerisity of Aquila Pharmacol-Toxicologica Report, 1971. Laparra, J., et al., Acta Therapeutica, 4:233, 1978. Volkner, Wolfgang Muller, Ewald, Micronucleus assay in bone marrow cells of the mouse with Pycnogenol. Cytotest Cell Research GmbH & Co., projects 143010 & 143021; Feb. 1989. Acute and chronic toxicity tests. International Bio-Research, Inc., Hanover, Germany, 1967-1971. Dumon, M., Michaud, J., Masquelier, J. Proanthocyanidin content in vegetable extracts to be used in the preparation of medicines. Bull. Soc. Pharm. Bordeaux, 129:51-65, 1990. |
|||
| Top
|
|||
|
|||